Lung transplantation for post‐COVID‐19 pulmonary fibrosis

COVID‐19 has affected over a billion people around the world, with over 2 million losing their lives (Worldometer). About 10% of patients infected with COVID‐19 develop a serious illness, including respiratory failure, that require advanced life‐supporting measures. Mortality among this subgroup exc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogia, Pratibha, Attawar, Sandeep, Singh, Vivek, Bhatnagar, Tarun, Sharma, Sanjay, Batra, Khushboo, Khare, Swapnil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524671/
https://www.ncbi.nlm.nih.gov/pubmed/34707876
http://dx.doi.org/10.1002/rcr2.862
Descripción
Sumario:COVID‐19 has affected over a billion people around the world, with over 2 million losing their lives (Worldometer). About 10% of patients infected with COVID‐19 develop a serious illness, including respiratory failure, that require advanced life‐supporting measures. Mortality among this subgroup exceeds 60%. We present a case of an otherwise healthy 34‐year‐old male who developed end‐stage pulmonary fibrosis following COVID‐19 infection. He achieved haemodynamic stability with mechanical ventilation and extracorporeal membrane oxygenation (ECMO) but did not show any sign of weaning off ECMO; however, he successfully underwent bilateral lung transplantation.

Ejemplares similares